πŸ‡ΊπŸ‡Έ FDA
Patent

US 10668171

Methods for modulating RNA splicing

granted A61KA61K31/519A61K31/711

Quick answer

US patent 10668171 (Methods for modulating RNA splicing) held by PTC THERAPEUTICS, INC. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/519, A61K31/711, A61K48/0025